Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I2 | O75469 | 1/20 | 0.49 |
| ▸ | HTR2A | P28223 | 1/20 | 0.47 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.46 |
| ▸ | NAAA | Q02083 | 2/20 | 0.45 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.44 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.44 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.44 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.44 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.44 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.42 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6680917 | 1.00 | NR1I2 (0.49) | NR1I2HTR2ACSNK1ESIGMAR1NAAA | |
| SCHEMBL10980554 | 1.00 | NR1I2 (0.49) | NR1I2HTR2ACSNK1ESIGMAR1NAAA | |
| SCHEMBL6681486 | 1.00 | NR1I2 (0.49) | NR1I2HTR2ACSNK1ESIGMAR1NAAA | |
| SCHEMBL11369217 | 1.00 | NR1I2 (0.49) | NR1I2HTR2ACSNK1ESIGMAR1NAAA | |
| SCHEMBL21633686 | 1.00 | NR1I2 (0.49) | NR1I2HTR2ACSNK1ESIGMAR1NAAA | |
| SCHEMBL23849703 | 1.00 | NR1I2 (0.49) | NR1I2HTR2ACSNK1ESIGMAR1NAAA | |
| SCHEMBL20291563 | 1.00 | NR1I2 (0.49) | NR1I2HTR2ACSNK1ESIGMAR1NAAA | |
| SCHEMBL21633712 | 1.00 | NR1I2 (0.49) | NR1I2HTR2ACSNK1ESIGMAR1NAAA | |
| SCHEMBL21633771 | 1.00 | NR1I2 (0.49) | NR1I2HTR2ACSNK1ESIGMAR1NAAA | |
| SCHEMBL11795720 | 1.00 | NR1I2 (0.49) | NR1I2HTR2ACSNK1ESIGMAR1NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0611207-B1 | Process for stabilisation of vesicles of amphiphilic lipids and composition for topical application containing these stabilized vesicles | OREAL (FR) | 2001-06-20 | — | — | EP | claimed |
| EP-0585170-B1 | Composition for treating acne which contains at least one derivative of salicyclic acid | OREAL (FR) | 1996-11-06 | — | — | EP | claimed |
| EP-0559502-B1 | Topical care composition containing lipidic vesicles encapsulating at least one mineral water | OREAL (FR) | 1996-03-20 | — | — | EP | claimed |
| EP-0584315-B1 | COSMETIC AND/OR PHARMACEUTICAL COMPOSITION CONTAINING A DISPERSION OF LIPIDIC VESICLES, PROCESS FOR THE PREPARATION OF SAID DISPERSION, AND LIPIDIC VESICLE DISPERSION | OREAL (FR) | 1995-09-20 | — | — | EP | claimed |
| EP-0611207-A1 | Process for stabilisation of vesicles of amphiphilic lipids and composition for topical application containing these stabilized vesicles | L'OREAL (FR) | 1994-08-17 | — | — | EP | claimed |
| EP-0584315-A1 | COSMETIC AND/OR PHARMACEUTICAL COMPOSITION CONTAINING A DISPERSION OF LIPIDIC VESICLES, PROCESS FOR THE PREPARATION OF SAID DISPERSION, AND LIPIDIC VESICLE DISPERSION. | OREAL (FR) | 1994-03-02 | — | — | EP | claimed |
| EP-0585170-A1 | Composition for treating acne which contains at least one derivative of salicyclic acid | L'OREAL (FR) | 1994-03-02 | — | — | EP | claimed |
| WO-1993024106-A1 | COMPOSITION COMPRISING A PROANTHOCYANIDIN OLIGOMER ENCAPSULATED IN A LIPOSOME | L'OREAL (FR) | 1993-12-09 | — | — | WO | claimed |
| EP-0559502-A1 | Topical care composition containing lipidic vesicles encapsulating at least one mineral water | L'OREAL (FR) | 1993-09-08 | — | — | EP | claimed |
| WO-1993015708-A1 | COSMETIC AND/OR PHARMACEUTICAL COMPOSITION CONTAINING A DISPERSION OF LIPIDIC VESICLES, PROCESS FOR THE PREPARATION OF SAID DISPERSION, AND LIPIDIC VESICLE DISPERSION | L'OREAL (FR) | 1993-08-19 | — | — | WO | claimed |
| EP-0946516-B1 | NEW HISTIDINE DERIVATIVES, PREPARATION PROCESS, AND THEIR USE AS FREE ANTIRADICAL AGENTS | OREAL (FR) | 2002-04-10 | — | — | EP | disclosed |
| EP-0611207-B1 | Process for stabilisation of vesicles of amphiphilic lipids and composition for topical application containing these stabilized vesicles | OREAL (FR) | 2001-06-20 | — | — | EP | disclosed |
| EP-0946516-A1 | NEW HISTIDINE DERIVATIVES, PREPARATION PROCESS, AND THEIR USE AS FREE ANTIRADICAL AGENTS | L'OREAL (FR) | 1999-10-06 | — | — | EP | disclosed |
| WO-1998024770-A1 | NEW HISTIDINE DERIVATIVES, PREPARATION PROCESS, AND THEIR USE AS FREE ANTIRADICAL AGENTS | L'OREAL (FR) | 1998-06-11 | — | — | WO | disclosed |
| EP-0585170-B1 | Composition for treating acne which contains at least one derivative of salicyclic acid | OREAL (FR) | 1996-11-06 | — | — | EP | disclosed |
| EP-0584315-A1 | COSMETIC AND/OR PHARMACEUTICAL COMPOSITION CONTAINING A DISPERSION OF LIPIDIC VESICLES, PROCESS FOR THE PREPARATION OF SAID DISPERSION, AND LIPIDIC VESICLE DISPERSION. | OREAL (FR) | 1994-03-02 | — | — | EP | disclosed |
| EP-0585170-A1 | Composition for treating acne which contains at least one derivative of salicyclic acid | L'OREAL (FR) | 1994-03-02 | — | — | EP | disclosed |
| WO-1993024106-A1 | COMPOSITION COMPRISING A PROANTHOCYANIDIN OLIGOMER ENCAPSULATED IN A LIPOSOME | L'OREAL (FR) | 1993-12-09 | — | — | WO | disclosed |
| EP-0559502-A1 | Topical care composition containing lipidic vesicles encapsulating at least one mineral water | L'OREAL (FR) | 1993-09-08 | — | — | EP | disclosed |
| WO-1993015708-A1 | COSMETIC AND/OR PHARMACEUTICAL COMPOSITION CONTAINING A DISPERSION OF LIPIDIC VESICLES, PROCESS FOR THE PREPARATION OF SAID DISPERSION, AND LIPIDIC VESICLE DISPERSION | L'OREAL (FR) | 1993-08-19 | — | — | WO | disclosed |